AzTrials
AzTrials

Unexpected AnxietyUSIANCT07246746

Use of an Infotainment System in MRI in Patients Suffering From Unexpected Anxiety.

A study testing Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire and Anxiety support procedure according to randomization: Innovision© or Hypnosis in people with Unexpected Anxiety, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

MRI scans are now considered essential for diagnosing or monitoring disease, and as a result, the number of MRI scans has increased significantly in recent years. Nevertheless, these routine examinations remain a source of apprehension and anxiety for some people. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Unexpected Anxiety
What is being tested?
Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire and Anxiety support procedure according to randomization: Innovision© or Hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFrance
Study dates
12 Jan 2026to Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals who have given their verbal consent
  • Individuals over the age of 18
  • Hospitalized or ambulatory individuals who are able-bodied and scheduled to undergo a brain MRI scan on the 1.5T A MRI machine at the Dijon University Hospital.
  • Individuals reporting anxiety about brain MRI for the first time upon admission by the radiology technician.

Who cannot join

  • Persons not affiliated with or not covered by a social security system
  • Persons subject to legal protection measures (guardianship, trusteeship)
  • Persons subject to judicial protection measures
  • Women who know they are pregnant
  • Adults who are incapable or unable to give their consent
  • Persons with contraindications to MRI
Show all 13Show fewer
  • Persons who have already undergone an MRI accompanied by hypnosis
  • Persons who do not speak French
  • Persons who cannot read French
  • Persons with cognitive disorders
  • Persons who have taken sedatives before the examination
  • Persons who regularly take anxiolytic medication and have increased their usual dose before the examination
  • Persons who have already participated in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU Dijon Bourgogne

    Dijon

    Nicolas MIGNOT, 03 80 29 30 31, nicolas.mignot@chu-dijon.fr

    Recruiting

Other trials in France

About this study

MRI scans are now considered essential for diagnosing or monitoring disease, and as a result, the number of MRI scans has increased significantly in recent years.

Nevertheless, these routine examinations remain a source of apprehension and anxiety for some people.

The objective of this study is to compare two methods of care, enabling anxious individuals to complete their MRI examination and obtain images of sufficient quality for the radiologist to read and interpret.

Being tested
Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire, Anxiety support procedure according to randomization: Innovision© or Hypnosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaireOther

    Assessment of patient anxiety

  • Anxiety support procedure according to randomization: Innovision© or HypnosisOther

    Hypnosis or Innovision device

Study groups in NCT07246746
Study groupRoleWhat they receive
Experimental Innovision©ExperimentalNot described
Receives: Other: Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire; Other: Anxiety support procedure according to randomization: Innovision© or Hypnosis
Hypnosis controlActive comparatorNot described
Receives: Other: Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire; Other: Anxiety support procedure according to randomization: Innovision© or Hypnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of brain MRI sequences reported as interpretable

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2025
  2. Study start12 Jan 2026
  3. Primary completionJan 2028 (estimated)
  4. Study completionJan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07246746
Sponsor's protocol ID
MIGNOT AOIparaM 2023
Acronym
USIA
Status last verified
Jan 2026
First submitted
26 Sep 2025
Last updated
15 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire and Anxiety support procedure according to randomization: Innovision© or Hypnosis in people with Unexpected Anxiety, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nicolas MIGNOT (03 80 29 30 31, nicolas.mignot@chu-dijon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of brain MRI sequences reported as interpretable (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in